Onsdag 28 Oktober | 18:15:27 Europe / Stockholm
Est. tid*
2027-11-23 07:10 Kvartalsrapport 2027-Q3
2027-08-25 07:10 Kvartalsrapport 2027-Q2
2027-05-26 07:10 Kvartalsrapport 2027-Q1
2027-03-16 N/A Årsstämma
2027-02-24 07:05 Bokslutskommuniké 2026
2026-11-26 07:10 Kvartalsrapport 2026-Q3
2026-08-25 - Kvartalsrapport 2026-Q2
2026-05-27 - Kvartalsrapport 2026-Q1
2026-03-26 - X-dag ordinarie utdelning FLUO 0.00 DKK
2026-03-25 - Årsstämma
2026-02-25 - Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-29 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-31 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-31 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18 - Årsstämma
2022-03-30 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26 - Bokslutskommuniké 2020
2021-02-09 - Årsstämma
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-14 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-09 - X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-29 - Kvartalsrapport 2019-Q3
2019-05-31 - Kvartalsrapport 2019-Q1
LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamt inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar av olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

FluoGuide A/S agrees on free-of-charge underwriting commitments regarding the exercise of warrants of series TO 1

2020-04-15 21:57:20
FluoGuide A/S (“FluoGuide” or "the Company”) is pleased to announce that the Company has agreed on free-of-charge underwriting of approximately 19% of outstanding TO 1 warrants. The underwriters’ guarantee is activated if not all of the warrants are exercised, in which case the underwriters will subscribe for shares corresponding to exercising up to 203,737 TO 1 warrants.

FluoGuide issued units in its IPO in 2019. Each unit consisted of three shares and one free warrant TO 1. During the exercise period each warrant holder has the possibility, for each warrant, to subscribe for one regular new FluoGuide share for DKK 5.95 per share. The exercise period starts on Thursday 16 April 2020 and ends on 7 May 2020. The warrants are traded on Spotlight Stock Market until 5 May 2020. The warrant holders are able to exercise their warrants until 7 May 2020 or sell them at the latest on 5 May 2020, by instructing their banks. It is important to follow the instructions from the bank and allow sufficient time for handling the instruction and payment to be sure to act before the exercise period expires. The warrants TO 1 cease after the exercise period and thereafter has no value.

At the time of this press release, the warrants are in the money, meaning that the share price of FluoGuide is above the warrant exercise price. It increases the likelihood that Company will receive the maximal amount (DKK 6.3 million, before cost) from the exercise of the warrants. FluoGuide has agreed on underwriting guarantees corresponding to approximately 19% of the total number of warrants. The underwriters’ guarantee is activated if not all of the warrants are exercised, in which case the underwriters will subscribe for shares corresponding to exercising up to 203,737 TO 1 warrants. This corresponds to approximately 19% of all outstanding warrants. Minimum proceeds of DKK 1.2 million (before costs) is therefore guaranteed. If the guarantee is to be activated, the subscription of shares from the guarantors will in practice take place through a directed share issue which in that case will be decided upon by the Board of Directors, with support from an authorization that is planned to be granted the Board at the upcoming Annual General Meeting, after the exercise period for the warrants. No compensation is given for the guarantee commitment.

Parties that have entered underwriting commitments are (Name, Underwriting commitment in DKK): Kurt Mähler, 319,741.10;  Eastbridge Capital AB, 297,500.00; Stefan Lundgren, 198,331.35; Peter Nilsson, 198,331.35; John Moll,198,331.35.

The terms for the warrants in brief: 

  • Exercise period: 16 April to 7 May 2020.
  • Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in FluoGuide at a subscription price of DKK 5.95 per share.
  • Issue volume: There is a total of 1,074,758 warrants of series TO 1 outstanding. The warrants can provide the Company with a total of DKK 6,394,810.10 (before issue costs) if all warrants are exercised.
  • The number of outstanding shares in FluoGuide before warrants are exercised: 9,455,268 shares.

Important dates in connection to the exercise period for warrants of series TO 1